Aarntzen, E., Lesterhuis, W. J., Van Rossum, M., Adema, G. J., Figdor, C. F., Punt, C., & De Vries, I. (2010). Skin-derived tumor specific T cells predict clinical outcome in dendritic cell vaccination studies in both stage III and IV melanoma patients. BioMed Central.

Aarntzen, EHJG, W J. Lesterhuis, M. Van Rossum, G J. Adema, C F. Figdor, CJA Punt, e IJM De Vries. Skin-derived Tumor Specific T Cells Predict Clinical Outcome in Dendritic Cell Vaccination Studies in Both Stage III and IV Melanoma Patients. BioMed Central, 2010.

Aarntzen, EHJG, et al. Skin-derived Tumor Specific T Cells Predict Clinical Outcome in Dendritic Cell Vaccination Studies in Both Stage III and IV Melanoma Patients. BioMed Central, 2010.